Long-Term Clinical and Angiographic Results of Sirolimus-Eluting Stent in Complex Coronary Chronic Total Occlusion Revascularization: The SECTOR Registry
- 17 October 2011
- journal article
- research article
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 24 (5) , 426-436
Abstract
Background: Drug‐eluting stents showed a better angiographic and clinical outcome in comparison with bare metal stent in chronic total occlusions (CTOs) percutaneous revascularization, however, great concerns still remain regarding the rate of restenosis and reocclusion in comparison with nonocclusive lesions. Aim: To evaluate angiographic and clinical outcomes after sirolimus‐eluting stent (SES) implantation in the setting of a “real world” series of complex CTOs. Methods and Results: From January 2006 to December 2008, 172 consecutive patients with 179 CTO lesions were enrolled into registry. Among these, successful recanalization was obtained in 144 lesions (80.4%) with exclusive SES implantation in 104 lesions. The 9–12 months angiographic follow‐up was executed in 85.5% of lesions with evidence of angiographic binary restenosis in 16.8% of lesions. Total stent length and number of stent implanted were recognized as independent predictors of restenosis (odds ratio [OR] 4.7, 95% confidence interval [CI] 1.28–107.09, P = 0.02) and (OR 5.8, 95% CI 1.39–23.55, P = 0.01), respectively. The 2‐year clinical follow‐up showed rates of target lesion revascularization, non‐Q wave myocardial infarction, and total major adverse cardiovascular events (MACEs) of 11.1%, 2%, and 13.1%, respectively. Cox proportional‐hazard analysis showed diabetes as independent predictor of MACEs (hazard ratio [HR] 4.832; 95% CI, 0.730–0.861; P = 0.028). Conclusions: Data from this registry demonstrate the long‐term efficacy and safety of SES implantation after complex CTOs recanalization. (J Interven Cardiol 2011;24:426–436)Keywords
This publication has 28 references indexed in Scilit:
- Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trialEuroIntervention, 2010
- Long-Term Follow-Up on a Large Cohort of “Full-Metal Jacket” Percutaneous Coronary Intervention ProceduresCirculation: Cardiovascular Interventions, 2009
- Clinical and Angiographic Outcomes With Sirolimus-Eluting Stents in Total Coronary OcclusionsJACC: Cardiovascular Interventions, 2009
- Three‐year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus‐eluting stents: Insights from the rapamycin‐eluting stent evaluated at rotterdam cardiology hospital—(RESEARCH) registryCatheterization and Cardiovascular Interventions, 2007
- A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: Rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) studyAmerican Heart Journal, 2007
- Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: A report from the total occlusion study of Canada (TOSCA)Catheterization and Cardiovascular Interventions, 2005
- Effect of Chronic Total Coronary Occlusion on Treatment StrategyThe American Journal of Cardiology, 2005
- Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusionsThe American Journal of Cardiology, 2005
- Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusionsJACC, 2003
- Percutaneous transluminal coronary angioplasty of chronic total occlusions. determinants of primary success and long-term clinical outcomeCatheterization and Cardiovascular Interventions, 2000